Loading company…
Mahana Therapeutics, Inc., based in San Francisco, develops digital therapeutics and software for healthcare providers.
Founded in 2018 and headquartered in San Francisco, US, Mahana Therapeutics, Inc. provides software for healthcare providers that streamlines workflows, offers data analytics and improves patient engagement, sold through annual subscriptions and multi-user licenses. Its most recent Series B round raised USD 61.00 mn, led by investors including Gurnet Point Capital and JAZZ Venture Partners. The company was co-founded by Simon Levy. In May 2025 it was acquired by Nerva.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in